August 12, 2024
“CervoMed (CRVO) The first Morgan Stanley pick we’ll look at is CervoMed, a clinical-stage medical research firm specializing in neurodegenerative diseases and conditions… Overall, the analyst expects positive clinical results and rates CRVO an Overweight (i.e., Buy). His $35 price… Continue Reading…
July 8, 2024
“Semiconductor company Nvidia (NASDAQ: NVDA) completed a 10-for-1 stock split in June, and fellow chipmaker Broadcom (NASDAQ: AVGO) has a 10-for-1 stock split planned for July. Savvy investors have gravitated toward both stocks. A company’s share price tends to increase about twice as fast as the S&P 500 (SNPINDEX:… Continue Reading…
October 18, 2021
“Elon Musk is now so wealthy that he has more money than Bill Gates and Warren Buffett combined. With his fortune clocking in at $236 billion (£171 billion), Musk is now not just the world’s richest person—he is richer than the two billionaires… Continue Reading…
Recent Comments